Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivity

被引:7
|
作者
Chunduri, HimaBindu [2 ]
Crumpacker, Clyde [3 ]
Sharma, Prem L. [1 ,2 ]
机构
[1] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30033 USA
[2] Vet Affairs Med Ctr, Atlanta, GA 30033 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
Replication; Attenuation; RT mutation; K65R; Lys65Arg; K65N; Lys65Asn; HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; 1ST-LINE ANTIRETROVIRAL THERAPY; THYMIDINE ANALOG MUTATIONS; NUCLEOCAPSID PROTEIN; MOLECULAR-MECHANISMS; COMBINATION THERAPY; INFECTED ADULTS; ENZYME FUNCTION; CELL-CULTURE;
D O I
10.1016/j.virol.2011.03.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In addition to K65R, the other mutation observed at HIV-1 RT codon 65 is K65N. While K65N appears to have a phenotypic effect similar to K65R, it is less frequent during clinical trials. We compared the relative impact of K -> N with respect to K -> R change on viral replication capacity (RC). Mutant viruses were created and replication kinetics assays were performed in PBM cells. Analysis of RCs revealed a significant loss in replication (p=0.004) for viruses containing K65N mutation in comparison to those with K65R mutation. RI processivity assays showed a significant decrease in the processivity of K65N RI in comparison to K65R RT. We demonstrated that the significant decrease in RC of K65N viruses is related to the impaired RI processivity of K65N RI in comparison to K65R, and that the selection of the K65R mutation may be favored in clinical use of antiretroviral drugs compared to K65N. Published by Elsevier Inc.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 50 条
  • [41] Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases
    Mar Álvarez
    Alba Sebastián-Martín
    Guillermo García-Marquina
    Luis Menéndez-Arias
    Scientific Reports, 7
  • [42] Relative fitness and tenofovir resistance levels of K70E and K65R HIV-1 RT mutants favours selection of K65R over K70E viruses in the presence of tenofovir
    Svarovskaia, E. S.
    Goodman, D.
    Ly, J.
    Eastoak-Siletz, A.
    White, K.
    LaFlamme, G.
    Margot, N. A.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2007, 12 : S110 - S110
  • [43] Strong decrease in viral replication capacity in HIV-1 containing both K65R and Q151M mutations
    Garcia-Perez, J.
    Perez-Olmeda, M.
    Sanchez-Palomino, S.
    Menendez-Arias, L.
    Valer, L.
    Garcia, F.
    Pumarola, T.
    Soriano, V.
    Alcami, J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S44 - S44
  • [44] Increasing prevalence of K65K and K66K in HIV-1 subtype B reverse transcriptase
    Telwatte, Sushama
    Brumme, Chanson J.
    Hearps, Anna C.
    Latham, Catherine F.
    Hayward, Joshua A.
    Sonza, Secondo
    Sluis-Cremer, Nicolas
    Harrigan, P. Richard
    Tachedjian, Gilda
    AIDS, 2016, 30 (18) : 2787 - 2793
  • [45] Differential influence of nucleoside analog resistance mutations K65R and L74V on the overall mutation rate and error specificity of HIV-1 reverse transcriptase.
    Shah, FS
    Curr, K
    Hamburgh, M
    Parniak, M
    Mitsuya, H
    Prasad, VR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 221A - 221A
  • [46] Antiviral Activity of Tenofovir Alafenamide Against HIV-1 Subtypes and Emergence of K65R
    Cox, Stephanie
    Margot, Nicolas
    Miller, Michael
    Callebaut, Christian
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (05) : 456 - 458
  • [47] Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    Deval, J
    White, KL
    Miller, MD
    Parkin, NT
    Courcambeck, J
    Halfon, P
    Selmi, B
    Boretto, J
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 509 - 516
  • [48] Molecular mechanism for the mutual exclusion of K65R and L74V substitutions in HIV-1 reverse transcriptase-mediated dideoxynucleoside resistance
    Deval, J
    Navarro, JM
    Selmi, B
    Courcambeck, J
    Boretto, J
    Halfon, P
    Sire, J
    Canard, B
    ANTIVIRAL THERAPY, 2003, 8 (03) : U45 - U46
  • [49] Rapid and sensitive real-time PCR assay for the K65R drug resistance mutation in SIV reverse transcriptase
    Johnson, Jeffrey A.
    Van Rompay, Koen K. A.
    Del Wart, Eric
    Heneine, Walid
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (09) : 912 - 916
  • [50] In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
    Parikh, UM
    Koontz, DL
    Chu, CK
    Schinazi, RF
    Mellors, JW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1139 - 1144